<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recently G alpha 16, a new <z:chebi fb="0" ids="15996">guanosine triphosphate</z:chebi> (<z:chebi fb="11" ids="15996">GTP</z:chebi>) binding protein alpha subunit has been described to be specifically expressed in human hematopoietic cells </plain></SENT>
<SENT sid="1" pm="."><plain>Expression of G alpha 16 was observed in human cell lines of myelomonocytic and T-lymphocytic origin, but not in human B-cell lines Raji and IM9 </plain></SENT>
<SENT sid="2" pm="."><plain>We studied the expression of G alpha 16 in human B cells corresponding to different stages of B-cell differentiation by means of reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blotting </plain></SENT>
<SENT sid="3" pm="."><plain>The human Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines Raji, Ramos, BJAB, the lymphoblastoid cell line SKW6.4, and the <z:e sem="disease" ids="C0032131" disease_type="Neoplastic Process" abbrv="">plasmocytoma</z:e> cell line U266 were devoid of G alpha 16 </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, G alpha 16 was detected in the human progenitor B cell lines Reh and Nalm-6 </plain></SENT>
<SENT sid="5" pm="."><plain>Using the <z:chebi fb="0" ids="30214">mu+</z:chebi>, k- cell line BLIN-1 (pre-B <z:mp ids='MP_0005384'>cell phenotype</z:mp>) and its derived subclone 1E8 (surface <z:chebi fb="0" ids="30214">mu+</z:chebi>, k+; B-<z:mp ids='MP_0005384'>cell phenotype</z:mp>) G alpha 16 expression was found to disappear on transition from pre-B to B-cell differentiation stage </plain></SENT>
<SENT sid="6" pm="."><plain>The analysis of a broad panel of human neoplastic B lymphocytes ranging from progenitor B-<z:hpo ids='HP_0006721'>acute lymphatic leukemia</z:hpo> (<z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-pre-B-ALL</z:e>), common <z:hpo ids='HP_0002488'>acute leukemias</z:hpo> (<z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">cALL</z:e>), <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B-ALL</z:e>, mature <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> to low grade B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> of B-cell type, leukemic centrocytic non-Hodgkins <z:hpo ids='HP_0002665'>lymphoma</z:hpo> [NHL], hairy cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>) showed that G alpha 16 expression is limited to progenitor and <z:e sem="disease" ids="C1292769" disease_type="Neoplastic Process" abbrv="">pre-B-ALL</z:e> cells </plain></SENT>
<SENT sid="7" pm="."><plain>Therefore, we conclude that within B-cell differentiation, G alpha 16 is expressed solely during early B cell ontogeny and downregulated during differentiation </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, G alpha 16 might be an important regulator involved in signaling processes in progenitor B cells </plain></SENT>
</text></document>